On the other hand, the tumor-promoting effect of the hepatitis C virus (HCV) transgene in the chronic inflammation-mediated HCC mouse model, was associated with increased Gal1 expression in the liver [16]. The gene discussed is LGALS1; the disease is neoplasm.